Genetic predisposition to papillary thyroid cancer Badanie predyspozycji genetycznej do raka brodawkowatego tarczycy
نویسندگان
چکیده
Approximately 5% of differentiated thyroid cancers are hereditary. Hereditary non-medullary thyroid cancer may occur as a minor component of familial cancer syndromes (e.g. familial adenomatous polyposis) or as a primary feature (familial non-medullary thyroid cancer [FNMTC]). Among FNMTC, PTC is the most common. Although a hereditary predisposition to non-medullary thyroid cancer is well established, the susceptibility genes are poorly known. Up to now, by linkage analysis using microsatellite markers, several putative loci have been described — 1q21, 6q22, 8p23.1-p22, and 8q24; however, validation studies have been unsuccessful. In the present review we discuss the results of linkage analysis and the most recent results of genome wide association studies (GWAS) with high resolution SNP (single nucleotide polymorphism) arrays. (Pol J Endocrinol 2010; 61 (5): 486–489)
منابع مشابه
Diagnostic imaging of medullary thyroid cancer Diagnostyka obrazowa raka rdzeniastego tarczycy
Medullary thyroid cancer (MTC) is an uncommon malignancy with a high tendency to metastasize both to lymph nodes and distant localizations. In recurrent disease the most important prognostic factors are the early diagnosis, localization of the recurrent lesions and adequate patient selection for further treatment. An important role in monitoring of patients with medullary thyroid cancer plays p...
متن کاملThree Cases of Familial Papillary Carcinoma of Thyroid in a Family and its Management in Rural Hospital
Papillary thyroid cancer (PTC) is one of the most common thyroid malignancies, with an increase in incidence rates over the past few decades. The exact cause of thyroid cancer in most patients is still unclear but the possibility of genetic predisposition to PTC cannot be overlooked. The literature review on familial papillary thyroid carcinoma was done. Its occurrence at an advanced stage in c...
متن کاملShould we be concerned about thyroid cancer in patients taking glucagon-like peptide 1 receptor agonists?
The question is complicated, as there are different types of thyroid cancer, and a causal relationship is hard to prove. Glucagon-like peptide 1 (GLP-1) receptor agonists can be safely used in all patients with thyroid cancers that are derived from the thyroid follicular epithelium (papillary and follicular thyroid cancer). However, they are currently contraindicated in patients with medullary ...
متن کاملBoth F-18 FDG-avidity and Malignant Shape of Cervical Lymph Nodes on PET/CT after Total Thyroidectomy Predict Resistance to High-dose I-131 Therapy in Patients with Papillary Thyroid Cancer
Objective: Resistance of metastatic lymph nodes (LNs) to high dose I-131 therapy is associated with high morbidity in patients with differentiated thyroid cancer. We evaluated the role of F-18 FDG PET/CT in the prediction of resistance to high dose I-131 therapy in patients with papillary thyroid cancer. Methods: The subjects were 307 patients who underwent total or near total thyroidectomy fol...
متن کاملAn Unusual Case Report: Occurrence of Renal Cell Carcinoma, Basal Cell Carcinoma and Chronic Lymphocytic Leukemia in a Case of Papillary Thyroid Carcinoma Treated with Radioactive Iodine
The standard therapy for thyroid cancer is total or near total thyroidectomy, followed by the administration of radioactive iodine for remnant ablation or residual disease. Patients with radioiodine therapy are predisposed to second malignant neoplasms in organs such as central nervous system (CNS), breast, prostate, kidney, bone marrow, salivary gland, and digestive tract. Exposure to carcinog...
متن کامل